retatrutide approval status eli lilly LLY: Lilly's Achieves Key Milestone in Phase III Eli Lilly's experimental obesity drug
Description
Since the expansion of approved uses to include weight loss, these medications have become increasingly popular
Start with 2 peptides maximum, establish tolerance and benefits, then consider adding a third only after further research
However, every journey is unique, and the results can hence differ from person to person
[Crossref] Scheen AJ (2017) Dulaglutide for the treatment of type 2 diabetes
Were getting larger, sicker and more difficult to treat, he said
Bohnen NI, Kotagal V, Mller MLTM, Koeppe RA, Scott PJH, Albin RL, et al
